Quantum dot-based molecular imaging of cancer cell growth using a clone formation assay

Geng,Xia‑Fei; Fang,Min; Liu,Shao‑Ping; Li,Yan

doi:10.3892/mmr.2016.5632

Quantum dot-based molecular imaging of cancer cell growth using a clone formation assay

Authors:
- Xia‑Fei Geng
- Min Fang
- Shao‑Ping Liu
- Yan Li
View Affiliations

Affiliations: Department of Oncology, Hubei Key Laboratory of Tumor Biological Behaviors and Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China, Medical Research Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China
Published online on: August 18, 2016 https://doi.org/10.3892/mmr.2016.5632
Pages: 3007-3012
Copyright: © Geng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This aim of the present study was to investigate clonal growth behavior and analyze the proliferation characteristics of cancer cells. The MCF‑7 human breast cancer cell line, SW480 human colon cancer cell line and SGC7901 human gastric cancer cell line were selected to investigate the morphology of cell clones. Quantum dot‑based molecular targeted imaging techniques (which stained pan‑cytokeratin in the cytoplasm green and Ki67 in the cell nucleus yellow or red) were used to investigate the clone formation rate, cell morphology, discrete tendency, and Ki67 expression and distribution in clones. From the cell clone formation assay, the MCF‑7, SW480 and SGC7901 cells were observed to form clones on days 6, 8 and 12 of cell culture, respectively. These three types of cells had heterogeneous morphology, large nuclear:cytoplasmic ratios, and conspicuous pathological mitotic features. The cells at the clone periphery formed multiple pseudopodium. In certain clones, cancer cells at the borderline were separated from the central cell clusters or presented a discrete tendency. With quantum dot‑based molecular targeted imaging techniques, cells with strong Ki67 expression were predominantly shown to be distributed at the clone periphery, or concentrated on one side of the clones. In conclusion, cancer cell clones showed asymmetric growth behavior, and Ki67 was widely expressed in clones of these three cell lines, with strong expression around the clones, or aggregated at one side. Cell clone formation assay based on quantum dots molecular imaging offered a novel method to study the proliferative features of cancer cells, thus providing a further insight into tumor biology.

View Figures

View References

1	Dowsett M, Nielsen TO, A'Hern R, Bartlett J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, et al: Assessment of Ki67 in breast cancer: Recommendations from the international Ki67 in breast cancer working group. J Natl Cancer Inst. 103:1656–1664. 2011. View Article : Google Scholar : PubMed/NCBI
2	Soltysova A, Altanerova V and Altaner C: Cancer stem cells. Neoplasma. 52:435–440. 2005.PubMed/NCBI
3	Franken NA, Rodermond HM, Stap J, Haveman J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc. 1:2315–2319. 2006. View Article : Google Scholar
4	Munshi A, Hobbs M and Meyn RE: Clonogenic cell survival assay. Methods Mol Med. 110:21–28. 2005.PubMed/NCBI
5	Scholzen T and Gerdes J: The Ki-67 protein: From the known and the unknown. J Cell Physiol. 182:311–322. 2000. View Article : Google Scholar : PubMed/NCBI
6	He X, Chen Z, Fu T, Jin X, Yu T, Liang Y, Zhao X and Huang L: Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis. BMC Cancer. 14:1532014. View Article : Google Scholar : PubMed/NCBI
7	Wang LW, Qu AP, Liu WL, Chen JM, Yuan JP, Wu H, Li Y and Liu J: Quantum dots-based double imaging combined with organic dye imaging to establish an automatic computerized method for cancer Ki67 measurement. Sci Rep. 6:205642016. View Article : Google Scholar : PubMed/NCBI
8	Weng KC, Nobel CO, Papahadjopolous-Sternberg B, Chen FF, Drummond DC, Kirpotin DB, Wang D, Hom YK, Hann B and Park JW: Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoposomes in vitro and in vivo. Nano Lett. 8:2851–2857. 2008. View Article : Google Scholar : PubMed/NCBI
9	Gokarna A, Jin LH, Hwang JS, Cho YH, Lim YT, Chung BH, Youn SH, Choi DS and Lim JH: Quantum dot-based protein micro- and nanarrays for detection of prostate cancer biomarkers. Proteomics. 8:1809–1818. 2008. View Article : Google Scholar : PubMed/NCBI
10	Chen LD, Liu J, Yu XF, He M, Pei XF, Tang ZY, Wang QQ, Pang DW and Li Y: The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis. Biomaterials. 29:4170–4176. 2008. View Article : Google Scholar : PubMed/NCBI
11	Chen C, Xia HS, Gong YP, Peng J, Peng CW, Hu MB, Zhu XB, Pang DW, Sun SR and Li Y: The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis. Biomaterials. 31:8818–8825. 2010. View Article : Google Scholar : PubMed/NCBI
12	Peng CW, Liu XL, Chen C, Liu X, Yang XQ, Pang DW, Zhu XB and Li Y: Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment. Biomaterials. 32:2907–2917. 2011. View Article : Google Scholar : PubMed/NCBI
13	Hamburger AW and Salmon SE: Primary bioassay of human tumor stem cells. Science. 197:461–463. 1997. View Article : Google Scholar
14	Chen C, Peng J, Xia HS, Yang GF, Wu QS, Chen LD, Zeng LB, Zhang ZL, Pang DW and Li Y: Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer. Biomaterials. 30:2912–2918. 2009. View Article : Google Scholar : PubMed/NCBI
15	Chen C, Sun SR, Gong YP, Qi CB, Peng CW, Yang XQ, Liu SP, Peng J, Zhu S, Hu MB, et al: Quantum dots-based molecular classification of breast cancer by quantitative spectroanalysis of hormone receptors and HER2. Biomaterials. 32:7592–7599. 2011. View Article : Google Scholar : PubMed/NCBI
16	Fang M, Yuan JP, Peng CW, Pang DW and Li Y: Quantum dots-based in situ molecular imaging of dynamic changes of collagen IV during cancer invasion. Biomaterials. 34:8708–8717. 2013. View Article : Google Scholar : PubMed/NCBI
17	Wang FB, Rong Y, Fang M, Yuan JP, Peng CW, Liu SP and Li Y: Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles. Biomaterials. 34:3816–3827. 2013. View Article : Google Scholar : PubMed/NCBI
18	Li X, Pan Y, Fan R, Jin H, Han S, Liu J, Wu K and Fan D: Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo. Carcinogenesis. 29:1587–1593. 2008. View Article : Google Scholar : PubMed/NCBI
19	Plumb JA: Cell sensitivity assays: Clonogenic assay. Methods Mol Med. 88:159–164. 2004.
20	Frangioni JV: New technologies for human cancer imaging. J Clin Oncol. 26:4012–4021. 2008. View Article : Google Scholar : PubMed/NCBI
21	Kim J, Piao Y and Hyeon T: Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev. 38:372–390. 2009. View Article : Google Scholar : PubMed/NCBI
22	Hong H, Zhang Y, Sun J and Cai W: Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today. 4:399–413. 2009. View Article : Google Scholar :
23	Peng CW, Tian Q, Yang GF, Fang M, Zhang ZL, Peng J, Li Y and Pang DW: Quantum-dots based simultaneous detection of multiple biomarkers of tumor stromal features to predict clinical outcomes in gastric cancer. Biomaterials. 33:5742–5752. 2012. View Article : Google Scholar : PubMed/NCBI
24	Resch-Genger U, Grabolle M, Cavaliere-Jaricot S, Nitschke R and Nann T: Quantum dots versus organic dyes as fluorescent labels. Nat Methods. 5:763–775. 2008. View Article : Google Scholar : PubMed/NCBI
25	Beresford MJ, Wilson GD and Makris A: Measuring proliferation in breast cancer: Practicalities and applications. Breast Cancer Res. 8:2162006. View Article : Google Scholar : PubMed/NCBI
26	Brabletz T, Jung A, Spaderna S, Hlubek F and Kirchner T: Opinion: Migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer. 5:744–749. 2005. View Article : Google Scholar : PubMed/NCBI
27	Watanabe T, Takahashi A, Suzuki K, Kurusu-Kanno M, Yamaguchi K, Fujiki H and Suganuma M: Epithelial-mesenchymal transition in human gastric cancer cell lines induced by TNF-α-inducing protein of Helicobacter pylori. Int J Cancer. 134:2373–2382. 2013. View Article : Google Scholar
28	Fang M, Yuan J, Peng C and Li Y: Collagen as a double-edged sword in tumor progression. Tumour Biol. 35:2871–2882. 2014. View Article : Google Scholar :
29	Gong P, Wang Y, Liu G, Zhang J and Wang Z: New insight into Ki67 expression at the invasive front in breast cancer. PLoS One. 8:e549122013. View Article : Google Scholar : PubMed/NCBI
30	Fidler IJ: The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer. 3:453–458. 2003. View Article : Google Scholar : PubMed/NCBI